Heart Failure Acute Clinical Trial
Official title:
How to Prevent Heart Failure Readmission by Using Lung Impedance Device (HOPE-HF Study)
The readmission of Heart Failure (HF) patients for exacerbation HF within 30-day is unmet goal. The mail reason for readmission is excessive accumulation of fluid in patient's lung. According our data (1,2) around 40% of HF patient have excessive lung fluid at discharge from HF hospitalization ("unacceptable" residual congestion on discharge). In other words, around 40% patients are discharged from HF hospitalization prematurely when they are not ready to be discharged. Only 60% of HF patients are discharged from HF admission with "acceptable" level of residual pulmonary congestion (2). There are some techniques to assess "readiness" of HF patients for discharge. Pulmonary congestion (lung fluid accumulation) may be assessed non-invasively by measurement Brain Natriuretic Peptide (BNP), (3,4), by lung ultrasound (LUS), (5-7) and by Lung Impedance (LI) method (1,2). LUS is operator depended technique. LI and BNP techniques are most reliable methods (2) and easy to use.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04751838 -
Development and Validation of a Simple-to-use Nomogram for Predicting In-hospital Mortality in Acute Heart Failure Patients Undergoing Continuous Renal Replacement Therapy
|
||
Active, not recruiting |
NCT04618601 -
Diuretic and Natriuretic Effect of High-dose Spironolactone in Patients With Acute Heart Failure
|
Phase 4 | |
Recruiting |
NCT06142474 -
SGLT2 Inhibitors in Patients With ADHF During Ventilator Weaning
|
Phase 3 | |
Active, not recruiting |
NCT05603247 -
The SWISSHEART Failure Network (SHFN)
|
||
Recruiting |
NCT03169803 -
Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF)
|
N/A | |
Not yet recruiting |
NCT06273397 -
Acetazolamide or Metolazone in Acute Heart Failure
|
N/A | |
Recruiting |
NCT03542123 -
Cardiac Output Autonomic Stimulation Therapy for Heart Failure - Hemodynamic Effects
|
N/A | |
Completed |
NCT04878263 -
Evaluation and Support Care Process Within the Care Pathway of Heart Failure Patients
|
N/A | |
Not yet recruiting |
NCT06442280 -
SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF
|
Phase 4 | |
Completed |
NCT04281849 -
Balance, Aerobic Capacity, Mobility and Strength in Patients Hospitalized for Heart Failure (BAMS-HF) Program
|
N/A | |
Not yet recruiting |
NCT04403659 -
Telemonitoring of Patients Admitted in Hospital at Home With Acute Decompensated Heart Failure - Pilot Study
|
N/A | |
Terminated |
NCT03574857 -
Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance
|
Phase 4 | |
Completed |
NCT03136198 -
B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial
|
Phase 2 | |
Terminated |
NCT03746002 -
Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing
|
Phase 4 | |
Active, not recruiting |
NCT03513653 -
Strain for Risk Assessment and Therapeutic Strategies in Patients With Acute Heart Failure (STRATS-AHF) Registry
|
||
Recruiting |
NCT06092437 -
Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients
|
N/A | |
Recruiting |
NCT05746923 -
Lesser Poland Cracovian Heart Failure Registry
|
||
Recruiting |
NCT06414928 -
Prognostic Model Heart Failure
|
||
Completed |
NCT04606927 -
Pragmatic Urinary Sodium-based Treatment algoritHm in Acute Heart Failure
|
N/A | |
Completed |
NCT03200860 -
Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure
|
Phase 2 |